Abstract:Objectives: The objectives of the study were to investigate the responses of different retinal ganglion cell (RGC) populations to diverse injuries [transient ischemia induced by acute ocular hypertension (AOH), excitotoxicity induced by intravitreal injection of 100 mM N‐methyl D‐aspartate (NMDA) or intra‐orbital optic nerve transection (IONT)] and protection with selective agonists of the tropomyosin related kinase B (TrkB) receptor, brain‐derived neurotrophic factor (BDNF) or 7,8‐Dihydroxyflavone (DHF) or with a voltage‐dependent calcium channel blocker (ITH12657). Methods: Adult Sprague–Dawley rats were used. In the first group, the left eye received a single intravitreal injection of 5 μL vehicle or 5 μg BDNF and was connected to a saline reservoir elevated above the eye to induce an acute ocular hypertension (AOH) and transient ischemia for 75 min. These rats were analysed at different survival intervals from 3 to 45 days. A second group were treated daily subcutaneously with vehicle or ITH5263 (10 mg/kg), or intraperitoneally with vehicle or DHF (5 mg/kg), starting 12 h prior to an intraocular injection of 100 mM N‐methyl‐D‐aspartate (NMDA) to induce retinal excitotoxicity. These rats were analysed at different survival intervals from 3 to 21 days. A third group received a left intra‐orbital optic nerve transection (IONT) to induce axotomy of the RGC population and were treated daily with an intraperitoneal injection of vehicle (0.9% NaCl containing 1% DMSO) or DHF (5 mg/kg diluted in vehicle). These rats were analysed at survival intervals from 3 to 60 days. The retinas were prepared as wholemounts and immunolabelled for Brn3a, melanopsin (m), Osteopontin (OPN) and the T‐box transcription factor T‐brain‐2 (Tbr2) to identify the following retinal ganglion cell populations: Brn3a + , melanopsin + , α‐like (OPN + ), α‐ON sustained RGCs (OPN + Tbr2 + ), α‐ON transient RGCs (OPN + Brn3a − Tbr2 − ) and α‐OFF like (OPN + Brn3a + ). The labelled RGCs were quantified automatically (Brn3a) or dotted manually and quantified with a graphic software, and distribution of the different populations were represented on topographical maps. Results: Our studies document that: (i) AOH induces progressive loss of Brn3a + RGCs and a significant but not progressive loss of m + RGCs. Treatment with BDNF afforded significant long‐lasting protection for both RGC populations. (ii) Intravitreal injection of NMDA resulted at 7 days in the abrupt significant loss of Brn3a + RGCs, αRGC and αONs‐RGCs without further progression, whereas αOFF‐RGCs died massively. Both m + RGCs and αONtRGCs appear fully resistant to NMDA‐induced excitotoxicity. Both ITH12657 or DHF protect Brn3a + RGC, αRGCs and αONs‐RGCs, but not αOFF‐RGCs. (iii) IONT and vehicle treatment result in a characteristic rapid loss of Brn3a, melanopsin RGCs, αRGCs, αONs‐RGCs and αOFF‐RGCs. DHFs protect Brn3a + RGC, m + RGCs, αRGCs and αONs‐RGCs, but not αOFF‐RGCs. Conclusions: Thus, three different RGC populations (Brn3a + , m + and α‐like) respond distinctly to different injuries and neuroprotective agents, further adding to the idea that each type of RGC has a unique response to injury and protection. Deciphering the molecular mechanisms of each RGC type will help understand neuronal responses to injury and its possible prevention.

Intrinsically photosensitive retinal ganglion cells are resistant to N-methyl-D-aspartic acid excitotoxicity

Melanopsin-expressing Retinal Ganglion Cells Are Relatively Resistant to Excitotoxicity Induced by N-methyl-d-aspartate

Idiosyncratic responses of RGCs to injury and protection

The Injury Resistant Ability of Melanopsin-Expressing Intrinsically Photosensitive Retinal Ganglion Cells

Characterization of non-alpha retinal ganglion cell injury responses reveals a possible block to restoring ipRGC function

Enhanced Survival of Melanopsin-expressing Retinal Ganglion Cells after Injury is Associated with the PI3 K/Akt Pathway

Roles of PI3K and JAK pathways in viability of retinal ganglion cells after acute elevation of intraocular pressure in rats with different autoimmune backgrounds

Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension.

Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma

Neuroprotection of Retinal Ganglion Cells Suppresses Microglia Activation in a Mouse Model of Glaucoma

Melanopsin ganglion cells in the mouse retina independently evoke pupillary light reflex

Retinal glial responses to optic nerve crush are attenuated in Bax-deficient mice and modulated by purinergic signaling pathways

Protection of Pattern Electroretinogram and Retinal Ganglion Cells by Oncostatin M after Optic Nerve Injury

The effect of retinal ganglion cell injury on light-induced photoreceptor degeneration

Long-Term Effect of Optic Nerve Axotomy on the Retinal Ganglion Cell Layer

Microglia mediate non-cell-autonomous cell death of retinal ganglion cells

Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model.

Inhibition of the NR2B-PSD95 Interaction Exerts Neuroprotective Effects on Retinal Ischemia-Reperfusion Injury

A Glycine Site-Specific NMDA Receptor Antagonist Protects Retina Ganglion Cells from Ischemic Injury by Modulating Apoptotic Cascades

Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in an Ex Vivo Human Glaucoma Model

Diversity in Homeostatic Calcium Set Points Predicts Retinal Ganglion Cell Survival Following Optic Nerve Injury in vivo